首页 | 本学科首页   官方微博 | 高级检索  
     

罗布泊来源胀果甘草根际枯草芽孢杆菌GA21次生代谢产物结构与活性初步研究
引用本文:靳婧,旭格拉·哈布丁,刘少伟,郭琳,蒋忠科,栾迎春,李展先,潘臻,孙承航. 罗布泊来源胀果甘草根际枯草芽孢杆菌GA21次生代谢产物结构与活性初步研究[J]. 中国医药生物技术, 2012, 7(1): 14-19. DOI: 10.3969/cmba.j.issn.1673-713X.2012.01.005
作者姓名:靳婧  旭格拉·哈布丁  刘少伟  郭琳  蒋忠科  栾迎春  李展先  潘臻  孙承航
作者单位:1. 中国医学科学院北京协和医学院医药生物技术研究所微生物化学室, 北京,100050
2. 新疆师范大学生命科学院, 乌鲁木齐,830054
3. 中原油田总医院, 河南濮阳,457001
4. 541004,桂林医学院药学院
基金项目:国家自然科学基金,微生物药物技术创新与新药创制产学研联盟
摘    要:目的分离鉴定枯草芽孢杆菌GA21发酵液中次生代谢产物并对其活性进行初步研究。方法采用TLC、HPLC等分离手段对次生代谢产物进行分离;通过HR-ESI质谱、1D-NMR和2D-NMR对其结构进行鉴定;以琼脂平板法检测其次生代谢产物对金黄色葡萄球菌、大肠杆菌、稻瘟菌、白色念珠菌的拮抗活性。结果分离得到两个异香豆素类次生代谢产物:GA21-20和GA21-26;其中GA21-20的化学结构与Amicoumacin B一致,但无抗细菌及真菌活性;GA21-26有抗真菌活性,但无抗细菌活性,分子量为435.20890,分子式为C21H29O7N3,是一新的3,4-二氢异香豆素类抗生素。GA21-26在2.5μg/纸片对白色念珠菌即可显示抑制活性,在80μg/纸片对水稻稻瘟菌显示抑制活性,表明GA21-26在拮抗医学条件致病真菌方面有潜在用途。结论枯草芽孢杆菌GA21能产生一系列3,4-二氢异香豆素类抗生素,其次级代谢产物值得进一步研究。

关 键 词:芽孢杆菌  枯草;异香豆素类;核磁共振波谱学;环境微生物学
收稿时间:2011-11-01

Preliminary study of structures and bioactivities of the secondary metabolites produced by Bacillus subtilis strain GA21
JIN Jing,HABDEN Xugela,LIU Shao-wei,GUO Lin,JIANG Zhong-ke,LUAN Ying-chun,LI Zhan-xian,PAN Zhen,SUN Cheng-hang. Preliminary study of structures and bioactivities of the secondary metabolites produced by Bacillus subtilis strain GA21[J]. Chinese Medicinal Biotechnology, 2012, 7(1): 14-19. DOI: 10.3969/cmba.j.issn.1673-713X.2012.01.005
Authors:JIN Jing  HABDEN Xugela  LIU Shao-wei  GUO Lin  JIANG Zhong-ke  LUAN Ying-chun  LI Zhan-xian  PAN Zhen  SUN Cheng-hang
Affiliation:Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China;College of Life Science,Xinjiang Normal University,Urumqi 830054,China;The General Hospital,ZhongYuan Oil Field,Puyang,Henan 457001,China;College of Pharmacy,Guilin Medical University,Guilin 541004,China
Abstract:Objective To isolate,purify and identify the secondary metablites from the fermentation broth produced by Bacillus subtilis strain GA21.Methods Different column chromatographies were used to isolate and purify the secondary metabolites.HR-ESI-MS,1D-NMR and 2D-NMR were used to analyze the structure of compounds GA21-20 and GA21-26.Agar plating method was used to analyze the inhibition activity of the secondary metabolites against Staphylococcus aureus,Escherichia coli,Pyricularia oryzae and Candida Albican.Results GA21-20 and GA21-26 were purified and structurally identified as a group of isocoumarin antibiotics.GA21-20 has the same structure with Amicoumacin B,but does not have anti-bacterial and anti-fungus activity.GA21-26 is a new member of isocoumacin antibiotic with the molecular formula of C21H29O7N3 and molecular weight of 435.2,and has anti-fungus activity.GA21-26 inhibits the growth of plant pathogenic fungi Pyricularia oryzae and Candida Albicans at 80μg per paper and 2.5μg per paper respectively.Conclusion A series of 3,4-dihydroisocoumarin can be isolated from the secondary metabolites produced by strain GA21 and more secondary metabolites need to be discovered from the fermentation broth of the strain GA21.
Keywords:Bacillus subtilis  Isocoumarins  Magnetic resonance spectroscopy  Environmental microbiology
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国医药生物技术》浏览原始摘要信息
点击此处可从《中国医药生物技术》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号